# ROME GS System Study

> **NCT07518004** · NA · RECRUITING · sponsor: **Senseonics, Inc.** · enrollment: 60 (estimated)

## Conditions studied

- Diabetes
- Diabetes Melletus, Type 1
- Diabetes Mellitus, Type 2

## Interventions

- **DEVICE:** Continuous Glucose Monitoring System

## Key facts

- **NCT ID:** NCT07518004
- **Lead sponsor:** Senseonics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-02-12
- **Primary completion:** 2028-08
- **Final completion:** 2028-12
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-04-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07518004

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07518004, "ROME GS System Study". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07518004. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*